The long-term objective of this research is to improve therapy for bone diseases through an understanding of the signaling pathways that lead to bone formation and bone loss. Previous studies have provided evidence that parathyroid hormone (PTH) activation of phospholipid/protein kinase C (PKC) signaling leads to increased bone resorption. The studies in the current proposal would elucidate the mechanisms of these pro-resorptive effects of PTH on phospholipid metabolism and protein kinase C in osteoblasts. The model is based on the following hypotheses: 1) PTH activates phospholipase D (PLD) through a signaling pathway that involves translocation of the small G proteins Rho A and Arf and increased intracellular calcium; 2) the diacylglycerols (DAGs) produced by the PLD action, together with the increased intracellular calcium, lead to activation of specific PKC isozymes, especially PKC-beta; 3) the downstream consequences are increased expression of interleukin-6 (IL-6) and osteoclast differentiating factor (ODF), and subsequent inhibition of osteoblast apoptosis and the promotion of osteoclastogenesis and bone resorption. Preliminary studies have demonstrated the presence of all of these proposed signaling components in the osteoblastic cell model to be used, and have shown PTH responsiveness by PLD, Rho A, Arf, PKC-alpha and -beta, IL-6 and ODF in these cells. The model will be tested by determining the effects of the small G-proteins and calcium on PLD activity both in vivo and in vitro and by determining their effects and those of the DAGs on PKC isozyme translocation and downstream responses. The studies will demonstrate whether antagonizing the actions of the small G-proteins with mutants and specific inhibitors disrupts the sequence of events and prevents the downstream responses. In addition, the impact on this pathway of PTH analogs that selectively or preferentially affect other signaling pathways will be determined. The findings will provide new understanding of parathyroid hormone signaling and actions in bone.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR011262-33
Application #
6624562
Study Section
General Medicine B Study Section (GMB)
Program Officer
Sharrock, William J
Project Start
1978-07-01
Project End
2004-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
33
Fiscal Year
2003
Total Cost
$257,250
Indirect Cost
Name
Northwestern University at Chicago
Department
Pharmacology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Wang, J; Stern, P H (2011) Dose-dependent differential effects of risedronate on gene expression in osteoblasts. Biochem Pharmacol 81:1036-42
Wang, J; Gilchrist, A; Stern, P H (2011) Antagonist minigenes identify genes regulated by parathyroid hormone through G protein-selective and G protein co-regulated mechanisms in osteoblastic cells. Cell Signal 23:380-8
Wang, Jun; Stern, Paula H (2010) Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active G?(12) or constitutively active RhoA. J Cell Biochem 111:1531-6
Yoshida, Tomohiko; Clark, Mary F; Stern, Paula H (2009) The small GTPase RhoA is crucial for MC3T3-E1 osteoblastic cell survival. J Cell Biochem 106:896-902
Kazmers, Nikolas H; Ma, Sophia A; Yoshida, Tomohiko et al. (2009) Rho GTPase signaling and PTH 3-34, but not PTH 1-34, maintain the actin cytoskeleton and antagonize bisphosphonate effects in mouse osteoblastic MC3T3-E1 cells. Bone 45:52-60
Singh, A T K; Gilchrist, A; Voyno-Yasenetskaya, T et al. (2005) G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells. Endocrinology 146:2171-5
Dossing, Debra A; Stern, Paula H (2005) Receptor activator of NF-kappaB ligand protein expression in UMR-106 cells is differentially regulated by parathyroid hormone and calcitriol. J Cell Biochem 95:1029-41
Singh, Amareshwar T K; Frohman, Michael A; Stern, Paula H (2005) Parathyroid hormone stimulates phosphatidylethanolamine hydrolysis by phospholipase D in osteoblastic cells. Lipids 40:1135-40
Radeff, Julie M; Nagy, Zsolt; Stern, Paula H (2004) Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. J Bone Miner Res 19:1882-91
Radeff, Julie M; Singh, Amareshwar T K; Stern, Paula H (2004) Role of protein kinase A, phospholipase C and phospholipase D in parathyroid hormone receptor regulation of protein kinase Calpha and interleukin-6 in UMR-106 osteoblastic cells. Cell Signal 16:105-14

Showing the most recent 10 out of 44 publications